Recordati licenses an innovative treatment for neurotrophic keratitis
Recordati announced the signing of an exclusive license agreement with MimeTech, an Italian development stage company fo…
Recordati announced the signing of an exclusive license agreement with MimeTech, an Italian development stage company fo…
The Galenica Group performed well in a complex market environment during the first six months of 2013. Net sales increas…
4SC AG (Frankfurt, Prime Standard: VSC), a drug discovery and development company, today announced that it has received,…